PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of California, San Diego La Jolla CA.\', \'Department of Pharmaceutical Outcomes and Policy University of Florida College of Pharmacy Gainesville FL.\', \'Leslie Dan Faculty of Pharmacy University of Toronto and Women\'s College Hospital Toronto Canada.\', \'Center for Health Equity Research and Promotion VA Pittsburgh Healthcare System Pittsburgh Pittsburgh PA.\', \'Division of General Internal Medicine University of Pittsburgh School of Medicine Pittsburgh PA.\', \'Division of Cardiology Department of Medicine University of Pittsburgh School of Medicine Pittsburgh PA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1161/JAHA.121.023235
?:doi
?:hasPublicationType
?:journal
  • Journal of the American Heart Association
is ?:pmid of
?:pmid
?:pmid
  • 34913359
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.674
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all